# Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-pla2r-antibody-levels-and-clinical-risk-factors-for-treatment-nonresponse/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sean J. Barbour,Fernando C. Fervenza,Dilshani Induruwage,Paul Brenchley,Brad H. Rovin,Michelle Hladunewich,Heather N. Reich,Richard Lafayette,Nabeel Aslam,Gerald B. Appel,Ladan Zand,Krzysztof Kiryluk,Lili Liu,Daniel Cattran,for the MENTOR Trial Investigators |
| Citations | 51 |
| DOI | 10.2215/cjn.0000000000000237 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pure.manchester.ac.uk/ws/files/281217360/cjasn-2023-000328-2.pdf |
| OpenAlex ID | https://openalex.org/W4384819294 |
| PMID | 37471101 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Dilshani Induruwage](https://scholariq.org/researchers/dilshani-induruwage/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.